Dermatology Infographic: Real-time Patient Insights from Medisafe
Highlights from the Dermatology Infographic
- The U.S. trails other nations in reported dermatology medication adherence on Medisafe at 74% – in line with adherence rates in the UK, Australia, and Turkey.
- Like many therapeutic areas, Saturday and Sunday prove the most challenging for dermatology medication adherence.
- Dermatology medication adherence peaks in the morning hours – but unlike some therapeutic areas, it stays relatively high throughout the day.
- Worldwide medication adherence rates for most dermatology conditions average 75% on Medisafe.
- Of the top dermatology drugs with the highest reported adherence on Medisafe, Merck, Novartis, Pfizer and Galderma hold 3 spots each.
What insights can we discover about your brand? Contact us to find out!
Full Dermatology Adherence Insights
Most Adherent Countries for Dermatology Meds
- Germany: 83%
- Italy: 81%
- Spain: 80%
- Argentina: 79%
- Brazil: 79%
- France: 79%
- Canada: 78%
- Netherlands: 78%
- Israel: 77%
- Mexico: 76%
- UK: 75%
- USA: 74%
- Australia: 73%
- Turkey: 73%
- India: 69%
How Day of Week Affects Dermatology Adherence
- Sunday: 72%
- Monday: 75%
- Tuesday: 75%
- Wednesday: 75%
- Thursday: 74%
- Friday: 74%
- Saturday: 72%
Adherence Rates by Type of Dermatology Treatment
- Bartonellosis: 84%
- Pruritus: 80%
- Calcineurin Inhibitors / Actinic Keratosis: 79%
- Pediculosis: 78%
- Acne Rosacea: 77%
- Contact Dermatitis: 76%
- Alopecia: 75%
- Acne Vulgaris / Eczema / Furunculosis: 74%
- Psoriasis / Hyperhidrosis: 73%
- Chloasma / Atopic Dermatitis: 72%
Why Dermatology Patients Say They Miss Doses
- Didn’t need dose: 29%
- Forgot/busy: 20%
- Other: 20%
- Med wasn’t nearby: 18%
- Ran out of meds: 9%
- Worried about side effects: 3%
- Worried about cost: 1%
Top Dermatology Meds with Highest Adherence
| Brand | Company | Adherence |
| Stelara | Janssen | 90% |
| Humira | Abbvie | 89% |
| Enbrel | Pfizer | 86% |
| Dupixent | Sanofi | 85% |
| Decadron | Merck | 83% |
| Sporanox | Janssen | 83% |
| Cosentyx | Novartis | 83% |
| Biaxin | AbbVie | 82% |
| Vibramycin | Pfizer | 80% |
| Minocin | Melinta | 80% |
| Diprosone | Merck | 80% |
| Sandimmune | Novartis | 79% |
| Mycostatin | Bristol-Myers Squibb | 79% |
| VFEND | Pfizer | 79% |
| Neoral | Novartis | 78% |
| Noxafil | Merck | 78% |
| Synalar | Medimetriks | 77% |
| Fungizone | Bristol-Myers Squibb | 77% |
| Sotret | Ranbaxy | 77% |
| Accutane | Roche | 76% |
| Claravis | Teva | 76% |
| MetroGel | Galderma | 76% |
| Zenatane | Dr. Reddy’s | 76% |
| Cotellic | Genentech | 76% |
| Solodyn | Ortho Dermatologics | 75% |
| Oracea | Galderma | 75% |
| Biaxin Filmtab | Abbott | 75% |
| Bactroban | GSK | 73% |
| Monodox | Aqua Pharmaceuticals | 73% |
| Protopic | Astellas | 72% |
| Soolantra | Galderma | 72% |
| Myorisan | Akorn | 71% |
| Aczone | Allergan | 69% |
| Acticlate | Aqua Pharmaceuticals | 68% |